Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 µM) and a range of other related tyrosine kinases (IC50>10 µM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity[1][2].
Molecular Weight:
387.84
Purity:
99.41
CAS Number:
[196612-93-8]
Formula:
C18H19ClFN7
Target:
EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
